Literature DB >> 26652843

Missense mutations in progranulin gene associated with frontotemporal lobar degeneration: study of pathogenetic features.

Celeste M Karch1, Lubov Ezerskiy2, Veronica Redaelli3, Anna Rita Giovagnoli3, Pietro Tiraboschi3, Giuseppe Pelliccioni4, Paolo Pelliccioni4, Dimos Kapetis5, Ilaria D'Amato3, Elena Piccoli3, Maria Giulia Ferretti3, Fabrizio Tagliavini3, Giacomina Rossi6.   

Abstract

GRN, the gene coding for the progranulin (PGRN) protein, was recognized as a gene linked to frontotemporal lobar degeneration (FTLD). The first mutations identified were null mutations giving rise to haploinsufficiency. Missense mutations were subsequently detected, but only a small subset has been functionally investigated. We identified missense mutations (C105Y, A199V, and R298H) in FTLD cases with family history and/or with low plasma PGRN levels. The aim of this study was to determine their pathogenicity. We performed functional studies, analyzing PGRN expression, secretion, and cleavage by elastase. GRN C105Y affected both secretion and elastase cleavage, likely representing a pathogenic mutation. GRN A199V did not alter the physiological properties of PGRN and GRN R298H produced only moderate effects on PGRN secretion, indicating that their pathogenicity is uncertain. In the absence of strong segregation data and neuropathological examinations, genetic, biomarker, and functional studies can be applied to an algorithm to assess the likelihood of pathogenicity for a mutation. This information can improve our understanding of the complex mechanisms by which GRN mutations lead to FTLD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Frontotemporal lobar degeneration; Functional analysis; GRN; Mutation; Pathogenetic; Progranulin

Mesh:

Substances:

Year:  2015        PMID: 26652843      PMCID: PMC4738142          DOI: 10.1016/j.neurobiolaging.2015.10.029

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  42 in total

1.  Serum biomarker for progranulin-associated frontotemporal lobar degeneration.

Authors:  Kristel Sleegers; Nathalie Brouwers; Philip Van Damme; Sebastiaan Engelborghs; Ilse Gijselinck; Julie van der Zee; Karin Peeters; Maria Mattheijssens; Marc Cruts; Rik Vandenberghe; Peter P De Deyn; Wim Robberecht; Christine Van Broeckhoven
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

2.  Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities.

Authors:  Dmitri Tolkatchev; Suneil Malik; Anna Vinogradova; Ping Wang; Zhigang Chen; Ping Xu; Hugh P J Bennett; Andrew Bateman; Feng Ni
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

3.  Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia.

Authors:  Odity Mukherjee; Jun Wang; Michael Gitcho; Sumi Chakraverty; Lisa Taylor-Reinwald; Shantia Shears; John S K Kauwe; Joanne Norton; Denise Levitch; Eileen H Bigio; Kimmo J Hatanpaa; Charles L White; John C Morris; Nigel J Cairns; Alison Goate
Journal:  Hum Mutat       Date:  2008-04       Impact factor: 4.878

4.  Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia.

Authors:  Julie van der Zee; Isabelle Le Ber; Sebastian Maurer-Stroh; Sebastiaan Engelborghs; Ilse Gijselinck; Agnès Camuzat; Nathalie Brouwers; Rik Vandenberghe; Kristel Sleegers; Didier Hannequin; Bart Dermaut; Joost Schymkowitz; Dominique Campion; Patrick Santens; Jean-Jacques Martin; Lucette Lacomblez; Tim De Pooter; Karin Peeters; Maria Mattheijssens; Martine Vercelletto; Marleen Van den Broeck; Marc Cruts; Peter P De Deyn; Frederic Rousseau; Alexis Brice; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2007-04       Impact factor: 4.878

5.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.

Authors:  Jennifer Gass; Ashley Cannon; Ian R Mackenzie; Bradley Boeve; Matt Baker; Jennifer Adamson; Richard Crook; Stacey Melquist; Karen Kuntz; Ron Petersen; Keith Josephs; Stuart M Pickering-Brown; Neill Graff-Radford; Ryan Uitti; Dennis Dickson; Zbigniew Wszolek; John Gonzalez; Thomas G Beach; Eileen Bigio; Nancy Johnson; Sandra Weintraub; Marsel Mesulam; Charles L White; Bryan Woodruff; Richard Caselli; Ging-Yuek Hsiung; Howard Feldman; Dave Knopman; Mike Hutton; Rosa Rademakers
Journal:  Hum Mol Genet       Date:  2006-09-01       Impact factor: 6.150

6.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17.

Authors:  Matt Baker; Ian R Mackenzie; Stuart M Pickering-Brown; Jennifer Gass; Rosa Rademakers; Caroline Lindholm; Julie Snowden; Jennifer Adamson; A Dessa Sadovnick; Sara Rollinson; Ashley Cannon; Emily Dwosh; David Neary; Stacey Melquist; Anna Richardson; Dennis Dickson; Zdenek Berger; Jason Eriksen; Todd Robinson; Cynthia Zehr; Chad A Dickey; Richard Crook; Eileen McGowan; David Mann; Bradley Boeve; Howard Feldman; Mike Hutton
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

Review 7.  Progranulin in frontotemporal lobar degeneration and neuroinflammation.

Authors:  Zeshan Ahmed; Ian R A Mackenzie; Michael L Hutton; Dennis W Dickson
Journal:  J Neuroinflammation       Date:  2007-02-11       Impact factor: 8.322

8.  Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.

Authors:  NiCole Finch; Matt Baker; Richard Crook; Katie Swanson; Karen Kuntz; Rebecca Surtees; Gina Bisceglio; Anne Rovelet-Lecrux; Bradley Boeve; Ronald C Petersen; Dennis W Dickson; Steven G Younkin; Vincent Deramecourt; Julia Crook; Neill R Graff-Radford; Rosa Rademakers
Journal:  Brain       Date:  2009-01-21       Impact factor: 13.501

9.  A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.

Authors:  Jonathan Beck; Jonathan D Rohrer; Tracy Campbell; Adrian Isaacs; Karen E Morrison; Emily F Goodall; Elizabeth K Warrington; John Stevens; Tamas Revesz; Janice Holton; Safa Al-Sarraj; Andrew King; Rachael Scahill; Jason D Warren; Nick C Fox; Martin N Rossor; John Collinge; Simon Mead
Journal:  Brain       Date:  2008-01-29       Impact factor: 13.501

10.  Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival.

Authors:  Philip Van Damme; Annelies Van Hoecke; Diether Lambrechts; Peter Vanacker; Elke Bogaert; John van Swieten; Peter Carmeliet; Ludo Van Den Bosch; Wim Robberecht
Journal:  J Cell Biol       Date:  2008-03-31       Impact factor: 10.539

View more
  4 in total

1.  Lysosomal Dysfunction and Other Pathomechanisms in FTLD: Evidence from Progranulin Genetics and Biology.

Authors:  Xiaolai Zhou; Thomas Kukar; Rosa Rademakers
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Atsttrin reduces lipopolysaccharide-induced neuroinflammation by inhibiting the nuclear factor kappa B signaling pathway.

Authors:  Lian Liu; Yuan Qu; Yi Liu; Hua Zhao; He-Cheng Ma; Ahmed Fayyaz Noor; Chang-Jiao Ji; Lin Nie; Meng Si; Lei Cheng
Journal:  Neural Regen Res       Date:  2019-11       Impact factor: 5.135

Review 3.  Unravelling Genetic Factors Underlying Corticobasal Syndrome: A Systematic Review.

Authors:  Federica Arienti; Giulia Lazzeri; Maria Vizziello; Edoardo Monfrini; Nereo Bresolin; Maria Cristina Saetti; Marina Picillo; Giulia Franco; Alessio Di Fonzo
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

4.  A novel phenotype in an Italian family with a rare progranulin mutation.

Authors:  Maria Claudia Russillo; Cristiano Sorrentino; Alfonso Scarpa; Claudia Vinciguerra; Giulio Cicarelli; Sofia Cuoco; Monica Gagliardi; Mariagrazia Talarico; Radha Procopio; Andrea Quattrone; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neurol       Date:  2022-07-20       Impact factor: 6.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.